• A post-market, single-center, randomized, double-blind, cross-over, prospective clinical study of the mild® procedure vs. sham in subjects with painful lumbar spinal stenosis. The objectives of this study are to assess the procedure feasibility, safety and functional outcomes in symptomatic subjects.
• A multi-center, open label, prospective clinical study to assess the clinical application and functional outcomes of symptomatic patients undergoing the Minimally Invasive Lumbar Decompression (mild®) treatment for lumbar spinal stenosis.
• A study for patients with chronic low back and leg pain to characterize activity levels before and after spinal cord stimulation therapy.

Dr. Grigsby is a co-investigator on the following clinical studies:

• Gabapentin Injection for the Treatment of Chronic, Intractable Pain: A Phase II trial investigates the efficacy, safety, and dosing of Gabapentin injection administered intrathecally via an implanted infusion system.
• Implantable System Performance Registry (ISPR): A clinical registry that monitors the use and performance of the Medtronic Inc. implantable pain relieving devices.

If you are interested in learning more about our open research studies please contact Whitney Michiels, Research Coordinator, at 707-252-9606